Results 191 to 200 of about 32,153 (233)

Emerging Therapeutic Innovations for Vitiligo Treatment. [PDF]

Curr Issues Mol Biol
Li W, Dong P, Zhang G, Hu J, Yang S.
europepmc   +1 more source

Cytotoxic T Lymphocyte Reactivity to gp100, MelanA/MART-1, and Tyrosinase, in HLA-A2-Positive Vitiligo Patients

, 2003
Rochelle L. Mandelcorn-Monson, Neil H. Shear, Eddy Yau, Suryaprakash Sambhara, Brian H. Barber, David Spaner, Mark DeBenedette   +6 more
openalex   +1 more source

Corrigendum to "Once-daily upadacitinib versus placebo in adults with extensive non-segmental vitiligo: a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-ranging study" [eClinicalMedicine 73(2024) 102655]. [PDF]

EClinicalMedicine
Passeron T, Ezzedine K, Hamzavi L, van Geel N, Schlosser BJ, Wu X, Huang X, Soliman AM, Rosmarin D, Harris JE, Camp HS, Pandya AG.   +11 more
europepmc   +1 more source

Evaluation of the clinical and sociodemographic features of patients with vitiligo from the central region of Romania. [PDF]

Front Med (Lausanne)
Fekete L, Fekete GL, Iantovics LB, Fekete JE, Bacârea V.   +4 more
europepmc   +1 more source

Association of Vitiligo with Sjögren's Syndrome

, 2003
Leopoldo F. Montes, Roswell R. Pfister, Francisco Elizalde, Walter H. Wilborn   +3 more
openalex   +1 more source

Multiple Cutaneous Adverse Reactions Secondary to Nivolumab Therapy in an Elderly Male. [PDF]

Cureus
Bhatia D, Gupta E, Bains A, Vedant D.
europepmc   +1 more source

Bioinformatics Analysis of Oxidative Stress-Related Genes and Immune Infiltration Patterns in Vitiligo. [PDF]

Clin Cosmet Investig Dermatol
Yang M, Wang H, Zhang R.
europepmc   +1 more source

Prevalence of vitiligo among patients attending the skin clinic at Mbarara Regional Referral Hospital, southwestern Uganda: A retrospective review. [PDF]

JAAD Int
Mundeli SP, Onguti AG, Kizito MS, Kitunzi MG, Obrien T.   +4 more
europepmc   +1 more source

<i>In vivo</i> 3D photoacoustic and ultrasound analysis of hypopigmented skin lesions: A pilot study. [PDF]

Photoacoustics
Kim M, Han JH, Ahn J, Kim E, Bang CH, Kim C, Lee JH, Choi W.   +7 more
europepmc   +1 more source

Investigating the molecular mechanism of purslane‑based vitiligo treatment using network pharmacology, molecular docking and <i>in vitro</i> analyses. [PDF]

Mol Med Rep
Zhang X, Meng L, Ran X, Li S, Wen C.
europepmc   +1 more source